N-Acetyl Semax Molecular Structure & Chemistry — Research Reference
N-Acetyl Semax is an acetylated variant of the synthetic ACTH analog Semax, distinguishing itself through an N-terminal acetyl group that significantly influences its molecular stability, physiochemical properties, and interactions within biological systems, making it a subject of focused inquiry in neuro-signaling research. Its specific structure and chemical modifications are central to understanding its observed behaviors in experimental models and potential research utility.
As a peptide of significant interest in experimental neuroscience, N-Acetyl Semax (NA-Semax) has been the focus of numerous indexed publications in scientific databases such as PubMed, exploring its molecular characteristics and mechanisms in various research contexts. Furthermore, its potential as a research tool has led to its registration in several studies on ClinicalTrials.gov, highlighting the ongoing scientific community’s interest in elucidating its biochemical and functional attributes for investigational purposes.
Introduction to N-Acetyl Semax: An Acetylated ACTH Analog
N-Acetyl Semax, often referred to by its alias NA-Semax, represents a sophisticated peptide construct primarily investigated within the sphere of neuro-signaling research. Classified as an ACTH analog, this compound is an acetylated variant of the parent peptide Semax, itself a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH), specifically ACTH(4-10). The deliberate acetylation at the N-terminus of Semax imbues N-Acetyl Semax with distinct physicochemical and pharmacokinetic properties that are of significant interest to researchers exploring peptide stability, bioavailability, and interaction with biological systems. Its development stems from a long lineage of research into neuropeptides and their capacity to modulate central nervous system functions, providing a focused tool for understanding the intricate molecular mechanisms underpinning neurocognitive processes and neuronal resilience. The strategic modification in N-Acetyl Semax aims to enhance its utility in preclinical and laboratory settings, making it a subject of extensive scientific inquiry.
The research landscape surrounding N-Acetyl Semax is characterized by its breadth and depth, with numerous publications indexed in PubMed detailing a wide array of experimental investigations. These studies span various disciplines, including neurobiology, pharmacology, and peptide chemistry, collectively contributing to a growing body of knowledge regarding its potential interactions within the brain and peripheral systems. Beyond basic scientific exploration, N-Acetyl Semax has also garnered attention in translational research, evidenced by the registration of several studies on ClinicalTrials.gov. While these registrations pertain to clinical research, it is crucial to emphasize that Royal Peptide Labs strictly provides N-Acetyl Semax for research use only, underlining its role as an investigative tool rather than a therapeutic agent for human administration. This strict adherence to research-only applications ensures that the peptide’s properties and effects are studied rigorously and ethically within controlled laboratory environments.
The core mechanism under investigation for N-Acetyl Semax revolves around its classification as an ACTH analog. Peptides derived from ACTH are known to exhibit pleiotropic effects on the central nervous system, influencing processes such as attention, memory, and stress responses, often independent of their classical adrenal-stimulating properties. N-Acetyl Semax, through its structural resemblance to these endogenous fragments, is hypothesized to engage similar neuro-signaling pathways, albeit with potentially altered efficacy or specificity due to its N-terminal acetylation. Researchers are particularly interested in how this modification might confer enhanced proteolytic stability, a common challenge for native peptides, thereby prolonging its presence and activity within biological matrices. Furthermore, alterations in lipophilicity due to acetylation may influence its ability to traverse biological barriers, such as the blood-brain barrier, which is a critical consideration for compounds intended for neurobiological research. The continued investigation into these aspects is vital for unraveling the full scope of N-Acetyl Semax’s potential as a research compound.
As an acetylated Semax variant, N-Acetyl Semax exemplifies the ongoing efforts in peptide biochemistry to design and synthesize analogs with improved pharmacological profiles for research purposes. Its structure, which we will delve into in subsequent sections, provides a fascinating case study in how small chemical modifications can profoundly impact a peptide’s interaction with its biological targets and overall stability. The extensive research conducted with N-Acetyl Semax underscores its value as a probe in understanding complex neurochemical networks and cellular responses. By exploring its molecular characteristics, synthesis, physicochemical properties, and mechanisms of action, this reference page aims to provide a comprehensive overview for researchers seeking to incorporate N-Acetyl Semax into their studies, always in adherence to the highest standards of research ethics and scientific rigor. The insights gained from studying N-Acetyl Semax continue to contribute to the broader understanding of neuropeptide function and the development of future research compounds.
Molecular Structure and Peptide Sequence of N-Acetyl Semax
N-Acetyl Semax is a synthetic heptapeptide, meaning it is composed of seven amino acid residues, and is distinguished by an N-terminal acetyl group. Its fundamental structure is directly derived from Semax, which itself is a derivative of the ACTH(4-10) fragment. To fully appreciate the molecular architecture of N-Acetyl Semax, it is essential to first understand its unacetylated progenitor. The sequence of Semax is typically represented as H-Pro-Gly-Pro-Pro-Gly-Pro-OH, although it is often amidated at the C-terminus, resulting in H-Pro-Gly-Pro-Pro-Gly-Pro-NH2. In the context of N-Acetyl Semax, the N-terminal hydrogen atom of the proline residue is replaced by an acetyl group (CH3CO-), yielding the full sequence: Ac-Pro-Gly-Pro-Pro-Gly-Pro-NH2. This precise arrangement of amino acids and the specific terminal modifications are critical determinants of the peptide’s overall three-dimensional conformation, its chemical properties, and its interactions with biological targets, making it a unique subject for neurobiological research.
The sequence Ac-Pro-Gly-Pro-Pro-Gly-Pro-NH2 is rich in proline residues, which are unique among the standard alpha-amino acids due to their cyclic pyrrolidine side chain. This cyclic structure restricts conformational flexibility around the alpha-carbon, imparting rigidity and specific turns or bends in the peptide backbone. The presence of multiple Pro-Gly-Pro motifs within N-Acetyl Semax is particularly noteworthy. Proline residues are known to induce β-turns and other secondary structural elements that are crucial for molecular recognition events, while glycine, being the simplest amino acid without a side chain, offers conformational flexibility. This interplay between rigidity (proline) and flexibility (glycine) in specific arrangements can significantly influence the peptide’s ability to adopt a bioactive conformation and bind to potential receptor sites. The C-terminal amidation (NH2) also serves to neutralize the negative charge typically found at the C-terminus of a free carboxylic acid, often enhancing metabolic stability and membrane permeability—a common strategy in peptide drug design for research applications.
The stereochemistry of the amino acids in N-Acetyl Semax is another vital aspect of its molecular structure. Customarily, peptides synthesized for research and biological applications utilize L-amino acids, which are the predominant enantiomeric form found in natural proteins. This ensures that the synthesized peptide maintains the correct three-dimensional orientation necessary for interactions with chiral biological systems, such as receptors or enzymes. Any deviation from the L-configuration, such as the incorporation of D-amino acids, would drastically alter the peptide’s conformational space and its biological activity. Therefore, the precise spatial arrangement and chirality of each proline and glycine residue within N-Acetyl Semax are meticulously controlled during synthesis to ensure the fidelity of its structure for consistent and reproducible research outcomes. The molecular weight of N-Acetyl Semax can be calculated based on its specific sequence and modifications, providing a crucial parameter for analytical characterization techniques such as mass spectrometry.
In summary, the molecular structure of N-Acetyl Semax is characterized by its acetylated N-terminus, its heptapeptide sequence of Ac-Pro-Gly-Pro-Pro-Gly-Pro-NH2, and its C-terminal amidation. Each of these features, from the specific amino acid sequence with its proline-rich motifs to the terminal chemical modifications, contributes to the peptide’s overall architecture and its potential biological profile as an ACTH analog. Researchers investigating N-Acetyl Semax recognize that understanding these structural intricacies is paramount for interpreting experimental results related to its stability, distribution, and mechanisms of action. This detailed structural knowledge forms the foundation for designing targeted experiments and for accurately comparing N-Acetyl Semax with its non-acetylated counterpart, Semax, or other related neuropeptides in various neuro-signaling research paradigms.
The Role of N-Terminal Acetylation in N-Acetyl Semax Chemistry
N-terminal acetylation is one of the most common post-translational modifications found in eukaryotic proteins, and its strategic application in synthetic peptides like N-Acetyl Semax is a deliberate chemical modification designed to profoundly influence the peptide’s characteristics. Chemically, N-terminal acetylation involves the enzymatic or synthetic attachment of an acetyl group (CH3CO-) to the alpha-amino group of the N-terminal amino acid. In the case of N-Acetyl Semax, this means the primary amine of the N-terminal proline residue is converted into an amide linkage. This seemingly minor alteration carries significant implications for the peptide’s stability, bioavailability, membrane permeability, and ultimately, its observed activity within biological systems under research conditions. The absence of the positive charge typically associated with the N-terminal alpha-amino group is a key consequence, impacting overall charge distribution and hydrophobicity, which are critical factors in biological interactions.
One of the primary benefits of N-terminal acetylation in peptide chemistry, particularly for research peptides, is the substantial enhancement of proteolytic stability. Native peptides are highly susceptible to degradation by exopeptidases, enzymes that cleave amino acids from the N- or C-termini of peptides. By acetylating the N-terminus, the free alpha-amino group, which is a common recognition site for aminopeptidases, is effectively blocked. This modification significantly reduces the rate at which the peptide can be enzymatically degraded, thereby increasing its half-life in biological matrices such as plasma, cerebrospinal fluid, or cell culture media. For researchers studying N-Acetyl Semax, this enhanced stability is invaluable, as it allows for longer observation windows and more consistent experimental results, minimizing variability introduced by rapid degradation of the research compound. This increased resistance to degradation is a crucial aspect when investigating peptides in complex biological environments, where endogenous proteases are abundant.
Beyond enzymatic stability, N-terminal acetylation also plays a pivotal role in modulating the physicochemical properties of N-Acetyl Semax, which in turn affects its pharmacokinetics in research models. The neutralization of the positive charge at the N-terminus by the acetyl group alters the peptide’s overall charge and increases its lipophilicity. This increase in hydrophobicity can be advantageous for several reasons. For compounds intended to act within the central nervous system, enhanced lipophilicity can improve the peptide’s ability to cross biological barriers, such as the blood-brain barrier (BBB). While the BBB is a formidable obstacle for many hydrophilic molecules, a moderate increase in lipophilicity can facilitate passive diffusion across lipid membranes. Researchers often hypothesize that N-Acetyl Semax may exhibit superior brain penetration compared to its non-acetylated counterpart due to this modification, although specific studies are required to confirm this in relevant research models. Such enhanced brain bioavailability would make N-Acetyl Semax a more effective tool for studying neuro-signaling pathways.
Furthermore, the N-terminal acetyl group can influence the peptide’s secondary structure and its affinity or selectivity for target receptors. By altering the electronic environment and hydrogen bonding potential at the N-terminus, acetylation can subtly change the conformational preferences of the peptide backbone. This, in turn, may impact how N-Acetyl Semax interacts with specific receptors or enzymes. While Semax itself is an ACTH analog, exhibiting affinity for melanocortin receptors and other targets, the acetylation may fine-tune these interactions, potentially leading to altered binding kinetics or downstream signaling events that are distinct from non-acetylated Semax. Researchers frequently compare N-Acetyl Semax with Semax to elucidate the precise role of this modification in modulating its biological activity and to identify any unique mechanisms of action. The N-terminal acetylation thus transforms N-Acetyl Semax into a powerful research tool, enabling more robust and prolonged investigations into its neurobiological effects and its potential as a modulator of cognitive and neuronal functions.
Chemical Synthesis and Purification Methodologies for N-Acetyl Semax
The robust production of high-purity N-Acetyl Semax for research applications relies heavily on established chemical synthesis and purification methodologies. The primary method employed for the synthesis of N-Acetyl Semax, like most research peptides of its size, is Solid-Phase Peptide Synthesis (SPPS). SPPS, pioneered by R. Bruce Merrifield, offers a highly efficient and systematic approach to construct peptides one amino acid at a time, covalently linked to an insoluble polymeric resin. This methodology allows for easy filtration and washing steps, simplifying the synthesis process and enabling automation. Two main strategies dominate SPPS: Fmoc (9-fluorenylmethyloxycarbonyl) chemistry and Boc (tert-butyloxycarbonyl) chemistry. For N-Acetyl Semax, Fmoc chemistry is generally preferred due to its milder reaction conditions, which minimize side reactions and epimerization, ensuring the integrity and stereochemical purity of the synthesized peptide. The process involves sequential coupling of protected amino acids to a growing peptide chain anchored to a resin, followed by deprotection of the N-terminal Fmoc group to expose the amino group for the next coupling cycle.
The synthesis of N-Acetyl Semax begins with the loading of the C-terminal amino acid (proline, in this case, for an amidated C-terminus using a Rink Amide resin) onto a suitable solid support resin. Each subsequent protected amino acid (Pro, Gly, Pro, Pro, Gly, Pro) is then added in a stepwise manner, typically activated with coupling reagents such as HATU or HBTU to form stable peptide bonds. Crucially, the N-terminal acetylation step is performed after the entire heptapeptide sequence has been assembled on the resin. Once the final N-terminal proline has been coupled and its Fmoc protecting group removed, the exposed alpha-amino group is reacted with an acetylating agent, most commonly acetic anhydride or acetyl chloride, in the presence of a base (e.g., diisopropylethylamine, DIEA). This reaction forms the stable N-terminal amide bond, completing the Ac-Pro-Gly-Pro-Pro-Gly-Pro-NH2 sequence. Following acetylation, the peptide is cleaved from the resin and simultaneously deprotected of its side-chain protecting groups using a strong acid cocktail, typically trifluoroacetic acid (TFA) containing various scavengers to prevent reattachment or modification of labile residues.
Upon cleavage and deprotection, the crude N-Acetyl Semax peptide is obtained as a mixture containing the desired product along with various synthesis byproducts, truncated sequences, and residual protecting group fragments. Therefore, rigorous purification is indispensable to achieve the high purity levels required for reliable research. The primary purification technique employed is Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). This method separates compounds based on their hydrophobicity; N-Acetyl Semax, being a relatively small and moderately hydrophobic peptide, is well-suited for RP-HPLC using C18 columns and gradients of acetonitrile in aqueous buffers (often containing TFA as an ion-pairing agent). Multiple passes or optimized gradients may be necessary to achieve purities exceeding 95-98%, which is a standard benchmark for research-grade peptides. Following RP-HPLC, the purified fractions containing N-Acetyl Semax are collected, pooled, and typically subjected to a lyophilization (freeze-drying) step to remove the solvent and obtain the peptide as a stable, amorphous powder.
Beyond RP-HPLC, additional purification steps or desalting procedures may be employed to ensure the removal of residual salts (such as TFA salts) that can interfere with downstream applications or alter the peptide’s precise concentration. Techniques like gel filtration or ion-exchange chromatography can be used if specific contaminants or salt forms need to be addressed. Thorough quality control is integrated throughout the synthesis and purification process. This includes monitoring coupling efficiencies, analyzing cleavage products, and ultimately, comprehensive analytical characterization of the final lyophilized product using techniques such as Mass Spectrometry (MS) and analytical RP-HPLC to confirm identity, purity, and molecular weight. These meticulous synthesis and purification protocols are critical for providing researchers with N-Acetyl Semax of consistent quality, enabling accurate and reproducible experimental data in their neuro-signaling investigations. The commitment to these high standards ensures the integrity of the research material supplied.
Physicochemical Properties and Stability Profile of N-Acetyl Semax
Understanding the physicochemical properties of N-Acetyl Semax is paramount for researchers seeking to accurately design experiments, ensure proper handling, and interpret results in neuro-signaling studies. As an acetylated heptapeptide, N-Acetyl Semax exhibits a unique combination of characteristics influenced by its specific amino acid sequence, terminal modifications, and overall structure. Key properties include its molecular weight, which can be precisely calculated from its sequence (Ac-Pro-Gly-Pro-Pro-Gly-Pro-NH2), its solubility in various solvents, and its lipophilicity. The N-terminal acetylation neutralizes the typically positively charged alpha-amino group, and the C-terminal amidation neutralizes the negatively charged carboxyl group, rendering the peptide net-neutral at physiological pH. This lack of ionizable groups within the peptide backbone at its termini contributes to a more hydrophobic character compared to its non-acetylated, non-amidated counterparts, influencing its partitioning behavior and interactions with biological membranes. This altered charge profile and increased hydrophobicity are critical determinants of its behavior in aqueous solutions and its potential for membrane permeability.
Solubility is a practical physicochemical property that significantly impacts research utility. N-Acetyl Semax is generally soluble in aqueous solutions, particularly at slightly acidic to neutral pH ranges, and also in various polar organic solvents, which can be useful for initial stock solution preparation. However, the precise solubility may vary based on the counter-ion present (e.g., acetate, TFA salt), which is a common consideration for lyophilized peptides. High concentrations of residual trifluoroacetate (TFA) can sometimes reduce solubility or introduce slight pH changes in dilute solutions. For preparing working solutions, high-purity distilled or deionized water is typically recommended, potentially with a small percentage of a co-solvent like acetonitrile or DMSO if higher concentrations or specific solvent properties are required. Care must be taken to ensure complete dissolution without aggregation, which can impact bioactivity and measurement accuracy. The specific proline-rich sequence can also influence its tendency to form secondary structures or aggregate under certain conditions, a factor researchers should be aware of when handling concentrated stock solutions.
The stability profile of N-Acetyl Semax is a critical consideration for maintaining its integrity and biological activity throughout the research lifecycle. Peptides are generally susceptible to various degradation pathways, including proteolysis, oxidation, deamidation, and aggregation. However, the N-terminal acetylation of N-Acetyl Semax significantly enhances its resistance to aminopeptidase degradation, as discussed previously, thereby extending its half-life in biological matrices. Furthermore, the absence of easily oxidizable residues like methionine, cysteine, or tryptophan contributes to a relatively good oxidative stability. Nevertheless, general peptide stability principles apply: exposure to elevated temperatures, extreme pH values, and prolonged light exposure can still compromise its structural integrity. Hydrolysis of peptide bonds can occur under highly acidic or basic conditions, and prolonged storage in solution, particularly at room temperature, can lead to degradation over time. The lyophilized powder form is inherently more stable than solutions and is the preferred state for long-term storage.
For optimal stability and to ensure reliable research outcomes, specific handling and storage conditions are recommended. A dry, cold environment is paramount for the long-term preservation of N-Acetyl Semax in its lyophilized form. Typically, storage at -20°C or even -80°C in a desiccated environment is advised to minimize degradation. Once reconstituted into a solution, the peptide’s stability decreases, and it should ideally be used promptly or stored in aliquots at low temperatures (e.g., -20°C or -80°C) to prevent freeze-thaw cycles that can induce aggregation or degradation. Researchers should consult the product-specific storage and handling guidelines provided by Royal Peptide Labs for detailed recommendations. The table below summarizes key physicochemical properties, providing a quick reference for researchers:
| Property | Description/Value (Approximate) | Research Significance |
|---|---|---|
| Peptide Sequence | Ac-Pro-Gly-Pro-Pro-Gly-Pro-NH2 | Defines primary structure and biological recognition. |
| Molecular Weight | ~650-750 Da (varies slightly by counter-ion) | Crucial for analytical verification (e.g., Mass Spectrometry) and concentration calculations. |
| N-Terminus | Acetylated (neutral) | Increased proteolytic stability, altered hydrophobicity. |
| C-Terminus | Amidated (neutral) | Increased proteolytic stability, altered membrane permeability. |
| Net Charge at pH 7.4 | Neutral | Influences interaction with charged molecules and membranes, overall lipophilicity. |
| Solubility | Water, polar organic solvents (e.g., DMSO, dilute ethanol) | Practical for stock solution preparation and experimental dosing. |
| Long-term Storage (Lyophilized) | -20°C to -80°C, desiccated | Ensures product integrity and minimizes degradation for extended periods. |
| Stability in Solution | Decreased; store aliquoted at -20°C to -80°C; avoid freeze-thaw cycles. | Critical for maintaining activity during active research phases. |
| Proteolytic Resistance | Enhanced (due to N-acetylation and C-amidation) | Prolonged half-life in biological matrices, enabling more robust studies. |
Mechanisms of Action and Neuro-signaling Pathways Under Investigation
The mechanisms of action for N-Acetyl Semax, as an acetylated ACTH analog, are a central focus of extensive neuro-signaling research. Its parent peptide, Semax, is derived from the ACTH(4-10) fragment, and peptides from this family are known to exert profound effects on the central nervous system largely independent of their corticosteroid-releasing activity. Research into N-Acetyl Semax typically explores its capacity to modulate various neurochemical systems and cellular pathways, contributing to observed effects on cognitive functions, neuroprotection, and stress responses in preclinical models. While the precise molecular targets are still being fully elucidated, current investigations suggest that N-Acetyl Semax interacts with several key components of neuro-signaling, distinguishing it as a valuable probe for understanding complex brain functions. It is crucial to frame these discussions within the context of ongoing research, acknowledging that findings are part of an evolving scientific understanding.
One primary area of investigation involves the potential of N-Acetyl Semax to
Frequently Asked Questions
What is N-Acetyl Semax?
N-Acetyl Semax, or NA-Semax, is a synthetic peptide and an acetylated variant of Semax, which itself is a synthetic analog of the adrenocorticotropic hormone (ACTH) fragment ACTH(4-10). It is primarily investigated in neuro-signaling research for its distinct chemical and biological properties conferred by the N-terminal acetyl group.
How does N-Acetyl Semax differ from Semax?
The primary difference lies in the N-terminal modification: N-Acetyl Semax possesses an acetyl group (-COCH3) attached to the N-terminus of the methionine residue, whereas Semax typically has a free amine group at its N-terminus. This acetylation can impact enzymatic stability, lipophilicity, and potentially receptor interactions in research models.
What is the peptide sequence of N-Acetyl Semax?
N-Acetyl Semax has the peptide sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro, where “Ac-” denotes the N-terminal acetyl group. This sequence is a modification of the core ACTH(4-10) fragment.
Why is N-terminal acetylation significant in N-Acetyl Semax research?
N-terminal acetylation is a common post-translational modification in native proteins and peptides. In synthetic peptides like N-Acetyl Semax, it can enhance resistance to aminopeptidase enzymatic degradation, alter charge distribution, influence hydrophobicity, and potentially impact membrane permeability and receptor binding affinity in experimental systems.
What analytical methods are used to characterize N-Acetyl Semax for research?
Standard analytical techniques for peptide characterization include High-Performance Liquid Chromatography (HPLC) for purity assessment, Mass Spectrometry (MS) for molecular weight and sequence verification, Nuclear Magnetic Resonance (NMR) spectroscopy for detailed structural elucidation, and amino acid analysis for composition confirmation.
In what research areas is N-Acetyl Semax primarily investigated?
N-Acetyl Semax is primarily investigated in neuro-signaling research, often within studies exploring cognitive processes, neuronal plasticity, stress response modulation, and interactions with various neurotransmitter systems in *in vitro* cell models and *in vivo* animal models.
What are the typical storage conditions for N-Acetyl Semax to maintain its stability?
For long-term storage, N-Acetyl Semax is typically stored as a lyophilized powder at -20°C or below, protected from light and moisture. Once reconstituted in an appropriate solvent, solutions should generally be stored at 4°C for short periods or aliquoted and frozen at -20°C or -80°C for extended use, minimizing freeze-thaw cycles.
Is N-Acetyl Semax considered an ACTH analog?
Yes, N-Acetyl Semax is considered an ACTH analog because its core peptide sequence (Met-Glu-His-Phe-Pro-Gly-Pro) is derived from the ACTH(4-10) fragment, with an additional N-terminal acetyl modification.
Scientific References
All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.